Pfizer (PFE) May Seek to Sell Non-Prescription Lipitor
Tweet
Share
E-mailGet Alerts PFE Hot Sheet
Join SI Premium – FREE
Pfizer (NYSE: PFE) may seek to sell non-prescription, or OTC, Lipitor, according to sources. Shares turned up into the close on the report.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
- Harrow study shows Iheezo cuts discomfort after eye injections
- Ionis to present olezarsen and ION775 data at ESC Congress 2026
Create E-mail Alert Related Categories
FDA, Insiders' BlogSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
